AGRI ENVI joint committee meeting

ENVI ECON ITRE -  Confirmation hearing of Teresa RIBERA RODRÍGUEZ, European Commissioner-designate for Clean, Just and Competitive Transition - Press point

ENVI ECON ITRE -  Confirmation hearing of Teresa RIBERA RODRÍGUEZ, European Commissioner-designate for Clean, Just and Competitive Transition

ENVI Committee meeting - Exchange of views with Commissioner Adina VALEAN

ENVI Committee meeting - Exchange of views with Dr Andrea AMMON, Director of the European Centre for Disease Prevention and Control (ECDC) - update on the COVID-19 situation

Due to strict sanitary measures to avoid COVID-19 spreading, Parliament has put in place temporary measures to allow members to fulfil their democratic rights and legislative duties. Parliament has put in place measures for Members to participate to committees from a distance.

ENVI Committee - Exchange of views with Frans TIMMERMANS,  Executive Vice-President of the European Commission in charge of the European Green Deal

ENVI committee meeting. Update by the Commission on the COVID-19 (Coronavirus) situation

ENVI Committee - Exchange of views with Swedish environment activist Greta Thunberg

ENVI committee meeting - Outbreak of Coronavirus pneumonia - Exchange of views with Andrea AMMON, Executive Director of the European Centre for Disease Prevention and Control.

ENVI committee meeting - Exchange of views with Thierry BRETON, Commissioner for Internal Market

ENVI Committee meeting - Public hearing ' Reducing Greenhouse gas emissions from EU-related maritime transport : what's next after the EU MRV '

ENVI Committee meeting - Exchange of views with Marija VUCKOVIC, Croatian Minister of Agriculture

ENVI Committee meeting - Exchange of views with Tomislav CORIC, Croatian Minister of Environment and Energy

Milan KUJUNDZIC - Minister of Health of the Republic of Croatia

ENVI Committee meeting - Exchange of views with Mr Milan KUJUNDZIC, Croatian Minister of Health

ENVI hearing on the revaluation of the wolf population in the EU

ENVI hearing on the revaluation of the wolf population in the EU - Analysis of the wolf population in the EU - Legal framework and international obligations

ENVI hearing on ' Revaluation of the Wolf Population in the EU '- Impacts on the environment and rural communities

ENVI committee meeting. Vote on the 2019 UN Climate Change Conference (COP25)

Hearing of Frans TIMMERMANS, Executive Vice President-designate, European Green Deal- Press point

Hearing of Frans TIMMERMANS, Executive Vice President-designate, European Green Deal- Q&A session

Hearing of Frans TIMMERMANS, Executive Vice President-designate, European Green Deal - Arrival and Opening statement

Jytte GUTELAND (S&D, SE), rapporteur and Pascal CANFIN (Renew, FR), ENVI Chair, give a press confenrece following the trilogue on Climate law, in the European Parliament in Brussels.

Press conference by Jytte GUTELAND (S&D, SE), rapporteur and Pascal CANFIN (Renew, FR), ENVI Chair following the trilogue on Climate law

Views of the trilogue meeting (20/04) and statements by Jytte GUTELAND (S&D, SE), rapporteur, and Pascal CANFIN (Renew, FR), ENVI Chair, following the agreement reached on the EU’s climate law. The new legislation increases the EU’s 2030 emissions reductions target from 40% to at least 55%, while boosting the contribution from removals that can bring the target to 57%.

Outcome of the trilogue on Climate law: views of the meeting, statement by Jytte GUTELAND (S&D, SE), rapporteur, and Pascal CANFIN (Renew, FR), ENVI Chair, and extracts of the press conference

Members of the Environment, Public Health and Food Safety (ENVI) Committee had an exchange of views on a new legislation for a faster authorisation procedure for COVID-19 vaccines that have already received EU authorisation, but which are being adapted to be effective against variants of the virus.

Quicker authorization procedure for adapted COVID-19 vaccines: exchange of views and statement by Cristian-Silviu BUŞOI (EPP, RO), Chair of the EP Committee on Industry, Research and Energy

Emer COOKE, European Medicines Agency (EMA) Executive Director update MEPs from the Environment, Public Health and Food Security Committee on the state of play in the evaluation and market authorisation of vaccines against COVID-19 and the next steps. And Members of the Budgets Control Committee and the Commission’s Director-General for Health and Food Safety (SANTE), Sandra GALLINA, discuss the current state of the EU’s advance purchase agreement on vaccines against COVID-19.

Update of purchase, evaluation and authorization of COVID-19 vaccines: extracts from the exchanges of views with Sandra GALLINA, Director-General of DG SANTE (CONT) and with Emer COOKE, EMA Executive Director (ENVI)

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) exchange views on the update of evaluation and authorization of COVID-19 vaccines, with Emer COOKE, Executive Director of the European Medicines Agency's (EMA), in the European Parliament in Brussels. Opening statements by Pascal CANFIN, ENVI Chair, and Emer COOKE. This transcription speech is the result of an automatic process. Check against delivery.

Update of evaluation and authorization of COVID-19 vaccines - Exchange of views with Emer COOKE, EMA Executive Director: opening statements by Pascal CANFIN, ENVI Chair, and Emer COOKE

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) exchange views on the update of evaluation and authorization of COVID-19 vaccines, with Emer COOKE, Executive Director of the European Medicines Agency's (EMA), in the European Parliament in Brussels. Questions & answers

Update of evaluation and authorization of COVID-19 vaccines - Exchange of views with Emer COOKE, EMA Executive Director: questions & answers

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) exchange views on the update of evaluation and authorization of COVID-19 vaccines, with Emer COOKE, Executive Director of the European Medicines Agency's (EMA), in the European Parliament in Brussels. Closing statements by Pascal CANFIN, ENVI Chair, and Emer COOKE.

Update of evaluation and authorization of COVID-19 vaccines - Exchange of views with Emer COOKE, EMA Executive Director: closing statements by Pascal CANFIN, ENVI Chair, and Emer COOKE

The Environment, Public Health and Food Security Committee (ENVI) hold a debate on COVID-19 variants and how effective vaccines are against them with representatives from the European Medicine Agency (EMA), the European Centre for Disease Prevention and Control (ECDC) and the World Health Organisation (WHO). Following this meeting, Pascal CANFIN (RE, FR), ENVI Chair, gives a statement on a faster authorisation process for updated vaccines and on the role of vaccination certificates.

COVID-19 variants and the vaccines' efficacy: statement by Pascal CANFIN (Renew, FR), ENVI Chair

Members of the EP Committee on Environment, Public Health and Food Safety exchange their views on COVID-19 variants and the vaccines' efficacy. Opening statements by Pascal CANFIN (Renew, FR), ENVI Chair, Marco CAVALERI, Head of Biological health threats and vaccines strategy and Chair of the COVID-19 Emergency Task Force, EMA, Bruno CIANCO, Head of Surveillance section, ECDC and Katherine O’BRIEN, Department of Immunization, Vaccines and Biologicals Director, World Health Organization, (WHO)

Exchange of views on COVID-19 variants and the vaccines' efficacy: opening statements by Pascal CANFIN (Renew, FR), ENVI Chair, Marco CAVALERI (EMA), Bruno CIANCO (ECDC) and Katherine O’BRIEN (WHO)

Members of the EP Committee on Environment, Public Health and Food Safety discuss the HERA Incubator - Anticipating the threat of COVID-19 variants. Opening statement by Commission. This transcription speech is the result of an automatic process. Check against delivery.

HERA Incubator - Anticipating the threat of COVID-19 variants: Opening statement by Pierre DELSAUX, Deputy Director General DG SANTE, European Commission

Members of the EP Committee on Environment, Public Health and Food Safety exchange their views on COVID19 variants and the vaccines' efficacy. MEPs debate. Questions and answers

Exchange of views on COVID19 variants and the vaccines' efficacy: MEPs debate. Questions and answers

Members of the EP Committee on Environment, Public Health and Food Safety discuss the HERA Incubator - Anticipating the threat of COVID-19 variants. MEPs debate. Questions and answers

HERA Incubator - Anticipating the threat of COVID-19 variants: MEPs debate. Questions and answers

During the plenary session of the European Parliament in Brussels (08-11 March 2021), MEPs participate in a joint debate on the European Semester: opening remark by Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade. Opening statements by Markus FERBER (EPP, DE), Lina GÁLVEZ MUÑOZ (S&D, ES), rapporteurs, Margarida MARQUES (S&D, PT), (BUDG); Nils UŠAKOVS (S&D, LV) BUDG, Ana Paula ZACARIAS, Portuguese Presidency, President in office of the European Council, and Valdis DOMBROVSKIS, Executive Vice-President of the European Commission in charge of an Economy that works for People, and Commissioner for Trade, and Nicolas SCHMIT, European Commissioner for Jobs and Social Rights, Pascal CANFIN (Renew, FR) (ENVI) and Victor NEGRESCU (S&D, RO) (CULT). This transcription speech is the result of an automatic process. Check against delivery.

European Semester: Opening statements

Members of the Public Health (ENVI) and Industry (ITRE) committees debate how to increase capacity and improve delivery of COVID-19 vaccines with pharmaceutical companies (AstraZeneca, Moderna, CureVac, Novavax, Johnson & Johnson, Pfizer Group and Sanofi Pasteur) and Commissioners Thierry Breton and Stella Kyriakides. Statements of MEPs : CANFIN Pascal (Renew, FR), BUŞOI Cristian-Silviu (EPP, RO), GUTELAND Jytte (S&D, SE), BALDASSARRE Simona (ID, IT). Statements of CEOs of pharmaceutical companies : SORIOT Pascal, CEO AstraZeneca, BANCEL Stéphane, CEO Moderna, HAAS Franz-Werner, CEO Curevac, ERCK Stan, CEO Novavax, HWANG Angela, CEO Pfizer, STOFFELS Paul, CEO Johnson & Johnson, TRIOMPHE Thomas, CEO Sanofi.

How to increase the capacity of COVID 19 vaccine production and improve delivery: extracts from the Joint ENVI-ITRE hearing

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Session 2- Presentations by Paul STOFFELS, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, Angela HWANG, President Global Biopharma, Pfizer Group, accompanied by Germain MORIN, VP Vaccines Supply Chain, Thomas TRIOMPHE, Executive Vice-President, Head of Sanofi Pasteur, Suerie MOON, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, Geneva.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Session 2 - CEOs of the pharmaceutical industry

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Q&A with CEOs of the pharmaceutical industry Paul STOFFELS, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson, Angela HWANG, President Global Biopharma, Pfizer Group, accompanied by Germain MORIN, VP Vaccines Supply Chain, Thomas TRIOMPHE, Executive Vice-President, Head of Sanofi Pasteur ,Suerie MOON, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, Geneva.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Q&A with ENVI and ITRE Members and CEOs of the pharmaceutical industry

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Session 1- Presentations by Pascal SORIOT, Chief Executive Officer, AstraZeneca, Stéphane BANCEL, Chief Executive Officer, Moderna, Franz-Werner HAAS, Chief Executive Officer, CureVac, accompanied by Antony BLANC, Chief Business Officer, Stan ERCK, President & Chief Executive Officer, Novavax.

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Session 1 - CEOs of the pharmaceutical industry

Members of the Committee on the Environment, Public Health and Food Safety (ENVI) and the Committee on Industry, Research and Energy (ITRE) have a joint hearing on "How to increase the capacity of COVID 19 vaccine production and improve delivery". Exchange of views with CEOs of the pharmaceutical industry on COVID 19 (Corona) vaccine production and delivery. Closing remarks by Thierry BRETON, European Commissioner for Internal Market.

Joint ENVI - ITRE Hearing Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Statement by Thierry BRETON, European Commissioner for Internal Market

343 rezultatov